Grant E. Blouse
CIK 1869883 · Chief Scientific Officer · last filed 2022-08-10
Grant E. Blouse is a Chief Scientific Officer who has filed 4 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing shows the insider bought $1.5K of CBIO on Aug 10, 2022. Across all open-market trades the lifetime net is +$7.2K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $9.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$9.3K
1
4
$7.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CBIO | Chief Scientific Officer | 628 | $14.75 | $9.3K | $7.2K | 4 | 2022-08-10 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-08-10 | CBIO | Buy (P) | +3,250 | $1.5K | EDGAR |
| 2022-02-23 | CBIO | Grant (A) | — | $0 | EDGAR |
| 2022-02-16 | CBIO | Buy (P) | +3,250 | $1.5K | EDGAR |
| 2021-08-11 | CBIO | Buy (P) | +1,163 | $4.2K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.